Evidence map›Paper›PMID 23808590›Full record

ArticleACS nano2013

Dysregulation of macrophage activation profiles by engineered nanoparticles.

Vamsi Kodali, Matthew H Littke, Susan C Tilton, Justin G Teeguarden, Liang Shi, Charles W Frevert, Wei Wang, Joel G Pounds, Brian D Thrall

Open access · greenAbstract read
In one paragraph

Article in ACS nano, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 157 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Vamsi KodaliPacific Northwest National Laboratory, Center for Nanotoxicology, and Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, United States.
Matthew H Littke
Susan C Tilton
Justin G Teeguarden
Liang Shi
Charles W Frevert
Wei Wang
Joel G Pounds
Brian D Thrall
Pacific Northwest National Laboratory · USOak Ridge National Laboratory · USUniversity of Washington · US

Funding

Project 3: Dosimetry and Structure-Activity Relationships for Nanomaterial Risk AU19ES019544 · NIEHS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI POUNDS, JOEL G · 2010 to 2014
$6.0M
Sytems Analysis of Nanoparticle BiocompatibilityR01ES016212 · NIEHS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI THRALL, BRIAN D. · 2007 to 2011
$1.9M
NIEHS NIH HHS R01 ES016212NIEHS NIH HHS U19 ES019544
6 · The paper itself

Abstract

Although the potential human health impacts from exposure to engineered nanoparticles (ENPs) are uncertain, past epidemiological studies have established correlations between exposure to ambient air pollution particulates and the incidence of pneumonia and lung infections. Using amorphous silica and superparamagnetic iron oxide (SPIO) as model high production volume ENPs, we examined how macrophage activation by bacterial lipopolysaccharide (LPS) or the lung pathogen Streptococcus pneumoniae is altered by ENP pretreatment. Neither silica nor SPIO treatment elicited direct cytotoxic or pro-inflammatory effects in bone marrow-derived macrophages. However, pretreatment of macrophages with SPIO caused extensive reprogramming of nearly 500 genes regulated in response to LPS challenge, hallmarked by exaggerated activation of oxidative stress response pathways and suppressed activation of both pro- and anti-inflammatory pathways. Silica pretreatment altered regulation of only 67 genes, but there was strong correlation with gene sets affected by SPIO. Macrophages exposed to SPIO displayed a phenotype suggesting an impaired ability to transition from an M1 to M2-like activation state, characterized by suppressed IL-10 induction, enhanced TNFα production, and diminished phagocytic activity toward S. pneumoniae. Studies in macrophages deficient in scavenger receptor A (SR-A) showed SR-A participates in cell uptake of both the ENPs and S. pneumonia and co-regulates the anti-inflammatory IL-10 pathway. Thus, mechanisms for dysregulation of innate immunity exist by virtue that common receptor recognition pathways are used by some ENPs and pathogenic bacteria, although the extent of transcriptional reprogramming of macrophage function depends on the physicochemical properties of the ENP after internalization. Our results also illustrate that biological effects of ENPs may be indirectly manifested only after challenging normal cell function. Nanotoxicology screening strategies should therefore consider how exposure to these materials alters susceptibility to other environmental exposures.

Indexed as

Air PollutantsAnimalsBone Marrow CellsFerric CompoundsGene Expression RegulationHumansImmunity, InnateInflammationLipopolysaccharidesMacrophage ActivationMacrophagesMiceNanoparticlesNanotechnologyOligonucleotide Array Sequence AnalysisOxidative StressAir PollutantsFerric Compoundsferric oxideLipopolysaccharides

Identifiers

PMID23808590
PMCPMC3756554
OpenAlexW1975279365

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.